Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
Jaguar Health, Inc. (NASDAQ:JAGX) has announced its participation in the Lytham Partners Fall 2024 Investor Conference, scheduled for October 1, 2024. The virtual event will feature a webcasted presentation by Lisa Conte, the company's founder, president, and CEO, at 1:15pm Eastern. Investors can access the webcast through a provided link, with a replay available after the event.
In addition to the presentation, Jaguar Health's management team will be available for one-on-one virtual meetings with investors throughout the conference. Interested parties can arrange meetings by contacting Lytham Partners or registering for the event through the provided link.
Jaguar Health, Inc. (NASDAQ:JAGX) ha annunciato la sua partecipazione alla Conferenza per Investitori Lytham Partners Fall 2024, programmata per il 1 ottobre 2024. L'evento virtuale presenterà una conferenza web tenuta da Lisa Conte, fondatrice, presidente e CEO dell'azienda, alle 1:15 pm Eastern. Gli investitori possono accedere alla diretta tramite un link fornito, con una registrazione disponibile dopo l'evento.
Oltre alla presentazione, il team di gestione di Jaguar Health sarà disponibile per incontri virtuali individuali con gli investitori durante tutta la conferenza. Le parti interessate possono organizzare incontri contattando Lytham Partners o registrandosi per l'evento tramite il link fornito.
Jaguar Health, Inc. (NASDAQ:JAGX) ha anunciado su participación en la Conferencia de Inversores Lytham Partners Fall 2024, programada para el 1 de octubre de 2024. El evento virtual contará con una presentación transmitida por Lisa Conte, fundadora, presidenta y CEO de la empresa, a las 1:15 pm Eastern. Los inversores podrán acceder a la transmisión a través de un enlace proporcionado, con una repetición disponible después del evento.
Además de la presentación, el equipo de dirección de Jaguar Health estará disponible para reuniones virtuales individuales con los inversores durante toda la conferencia. Las partes interesadas pueden organizar reuniones contactando a Lytham Partners o registrándose para el evento a través del enlace proporcionado.
재규어 헬스 주식회사(NASDAQ:JAGX)가 리탐 파트너스 2024 가을 투자자 회의에 참가한다고 발표했습니다. 이 행사는 2024년 10월 1일에 예정되어 있으며, 가상 이벤트로 리사 콘트 회사 창립자이자 회장, CEO가 동부 표준시 기준 오후 1시 15분에 발표할 예정입니다. 투자자들은 제공된 링크를 통해 웹캐스트에 접근할 수 있으며, 이벤트 종료 후 다시 볼 수 있는 서비스도 제공됩니다.
발표 외에도 재규어 헬스의 관리팀은 컨퍼런스 기간 동안 투자자들과의 1:1 가상 회의를 위해 대기하고 있습니다. 관심 있는 분들은 리탐 파트너스에 연락하거나 제공된 링크를 통해 행사에 등록하여 회의를 정리할 수 있습니다.
Jaguar Health, Inc. (NASDAQ:JAGX) a annoncé sa participation à la Conférence des Investisseurs Lytham Partners Automne 2024, prévue pour le 1er octobre 2024. L'événement virtuel comprendra une présentation diffusée en direct par Lisa Conte, la fondatrice, présidente et PDG de l'entreprise, à 13h15, heure de l'Est. Les investisseurs peuvent accéder au webinaire via un lien fourni, avec une rediffusion disponible après l'événement.
En plus de la présentation, l'équipe de direction de Jaguar Health sera disponible pour des réunions virtuelles individuelles avec les investisseurs pendant toute la conférence. Les parties intéressées peuvent organiser des réunions en contactant Lytham Partners ou en s'inscrivant à l'événement via le lien fourni.
Jaguar Health, Inc. (NASDAQ:JAGX) hat seine Teilnahme an der Lytham Partners Herbst 2024 Investorenkonferenz angekündigt, die für den 1. Oktober 2024 geplant ist. Die virtuelle Veranstaltung wird eine Präsentation von Lisa Conte, der Gründerin, Präsidentin und CEO des Unternehmens, um 13:15 Uhr Eastern beinhalten. Investoren können über einen bereitgestellten Link auf das Webcast zugreifen, mit einer Wiederholung, die nach der Veranstaltung verfügbar ist.
Zusätzlich zur Präsentation wird das Management-Team von Jaguar Health während der gesamten Konferenz für eins-zu-eins virtuelle Meetings mit Investoren zur Verfügung stehen. Interessierte Parteien können Meetings arrangieren, indem sie Lytham Partners kontaktieren oder sich über den bereitgestellten Link für die Veranstaltung registrieren.
- None.
- None.
SAN FRANCISCO, CA / ACCESSWIRE / September 25, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference , taking place virtually on Tuesday, October 1, 2024.
Company Webcast
The webcasted presentation will take place at 1:15pm Eastern on Tuesday, October 1, 2024. The webcast can be accessed by clicking here . The webcast will also be available for replay following the event.
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/fall2024invreg/ .
About the Jaguar Health Family of Companies
Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi ® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.
For more information about:
Jaguar Health, visit https://jaguar.health
Napo Pharmaceuticals, visit www.napopharma.com
Napo Therapeutics, visit napotherapeutics.com
Magdalena Biosciences, visit magdalenabiosciences.com
Visit the Make Cancer Less Shitty patient advocacy program at makecancerlessshitty.com and on X , Facebook & Instagram
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements." These include statements regarding Jaguar's expectation that Jaguar management will present at the Lytham Partners Fall 2024 Investor Conference. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.
CONTACT:
hello@jaguar.health
Jaguar-JAGX
SOURCE: Jaguar Health, Inc.
View the original press release on accesswire.com
FAQ
When is Jaguar Health (JAGX) participating in the Lytham Partners Fall 2024 Investor Conference?
What time is Jaguar Health's (JAGX) webcasted presentation at the Lytham Partners conference?
Who will be presenting for Jaguar Health (JAGX) at the Lytham Partners Fall 2024 Investor Conference?
How can investors attend one-on-one meetings with Jaguar Health (JAGX) management during the conference?
